search
Back to results

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

Primary Purpose

Brain Neoplasms, Brain Tumor, Brain Cancer

Status
Completed
Phase
Phase 1
Locations
France
Study Type
Interventional
Intervention
MR-guided Laser Interstitial Thermal Therapy System
Sponsored by
BioTex, Inc.
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Brain Neoplasms focused on measuring MR-guided therapy, Laser interstitial thermal therapy, brain metastasis, Magnetic Resonance Thermal imaging (MRTI)

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Patients 18 years of age or older
  • Patients with brain metastasis located in the brain hemispheres
  • Patient with a brain metastasis smaller or equal to 4 cm in diameter
  • Patient with primary brain tumor smaller or equal to 4 cm in diameter
  • Patient previously treated with other therapeutic techniques ( radio-therapy, chemotherapy, immunotherapy) which have failed.

Exclusion Criteria:

  • Patients less than 18 years old,
  • Patients presenting contra indication for MRI studies
  • Patient for which the primary cancer is melanoma or kidney tumors
  • Patients having a mean life duration longer than 3 months (due to the primary cancer)

Sites / Locations

  • Hospital Lariboisiere

Outcomes

Primary Outcome Measures

12 month morbidity and mortality

Secondary Outcome Measures

Mid and long term post-intervention complications,
Contra indication for the technique,
Optimize clinical and logistic intervention protocols,
Mean procedure duration
Mean procedure cost

Full Information

First Posted
October 23, 2006
Last Updated
December 30, 2009
Sponsor
BioTex, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00392119
Brief Title
MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors
Official Title
The Clinical Evaluation of the Stereotactic, MR Guided, Laser Interstitial Thermal Therapy (LITT ) for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors - a Phase I Study With Direct Patient Benefice
Study Type
Interventional

2. Study Status

Record Verification Date
December 2009
Overall Recruitment Status
Completed
Study Start Date
October 2006 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
December 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
BioTex, Inc.

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to determine if the stereotactic, MR guided, laser interstitial thermal therapy treatment technique can be safety and efficiently used for human brain metastasis and primary brain tumors.
Detailed Description
This new "minimally invasive" technique has been tested so far, with success, on animal brain tumor models and on human liver metastasis. The main purpose of this study is to determine if the stereotactic, MR guided, laser interstitial thermal therapy treatment technique can be safety and efficiently used for the human brain metastasis and primary brain tumors. As secondary objectives for this clinical study, the following are to be explored: Eventual evaluation of the eventual mid and long term post-intervention complications, Evaluate the contra indication for the technique, Evaluate and optimize clinical and logistic intervention protocols, Evaluate the mean duration for the procedure, Evaluate the mean cost for the procedure The clinical trial will include a statistical sample of 12-18 treatments and will run over a period of 18 months. The inclusion period will be for 6 months and the patients will be followed up during 12 months post intervention. The clinical trial will be performed at the Lariboisiere University Hospital of Paris and the patients will be coming from all the Assistance Publique de Paris ( APHP ) hospitals

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Brain Neoplasms, Brain Tumor, Brain Cancer, Recurrent Brain Tumor
Keywords
MR-guided therapy, Laser interstitial thermal therapy, brain metastasis, Magnetic Resonance Thermal imaging (MRTI)

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
18 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Device
Intervention Name(s)
MR-guided Laser Interstitial Thermal Therapy System
Primary Outcome Measure Information:
Title
12 month morbidity and mortality
Secondary Outcome Measure Information:
Title
Mid and long term post-intervention complications,
Title
Contra indication for the technique,
Title
Optimize clinical and logistic intervention protocols,
Title
Mean procedure duration
Title
Mean procedure cost

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients 18 years of age or older Patients with brain metastasis located in the brain hemispheres Patient with a brain metastasis smaller or equal to 4 cm in diameter Patient with primary brain tumor smaller or equal to 4 cm in diameter Patient previously treated with other therapeutic techniques ( radio-therapy, chemotherapy, immunotherapy) which have failed. Exclusion Criteria: Patients less than 18 years old, Patients presenting contra indication for MRI studies Patient for which the primary cancer is melanoma or kidney tumors Patients having a mean life duration longer than 3 months (due to the primary cancer)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Alexandre Carpentier, M.D./ Ph.D.
Organizational Affiliation
Hospital Lariboisiere, Paris, France
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Eric Vicaut, Ph.D.
Organizational Affiliation
Hospital Lariboisiere, Paris, France
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Daniel Reizine, M.D.
Organizational Affiliation
Hospital Lariboisiere, Paris, France
Official's Role
Study Director
Facility Information:
Facility Name
Hospital Lariboisiere
City
Paris
ZIP/Postal Code
75475
Country
France

12. IPD Sharing Statement

Citations:
PubMed Identifier
22109661
Citation
Carpentier A, McNichols RJ, Stafford RJ, Guichard JP, Reizine D, Delaloge S, Vicaut E, Payen D, Gowda A, George B. Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011 Dec;43(10):943-50. doi: 10.1002/lsm.21138. Epub 2011 Nov 22.
Results Reference
derived

Learn more about this trial

MR Guided Laser Interstitial Thermal Therapy for the "Minimal Invasive" Treatment of Brain Metastasis and Primary Brain Tumors

We'll reach out to this number within 24 hrs